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Introduction
Defects of proteins of the nuclear envelope are now recog-
nized as a vast group of heterogeneous rare inherited dis-
eases. The first reported nuclear envelope-related disease,
has been the X-linked form of the Emery-Dreifuss muscu-
lar dystrophy (EDMD1, OMIM#310300), a condition char-
acterized by muscle weakness and wasting usually with a
humeroperoneal distribution in the first stages, early joint
contractures of Achilles tendons, elbows, neck and spine,
and cardiac involvement featuring conduction defects,
arrhythmias, subsequent dilated cardiomyopathy and fre-
quently responsible of sudden death. EDMD1 is due to
mutation of the EMD gene encoding emerin. Defects of
A-type lamins (or Lamin A and C), two other nuclear
envelope proteins were identified shortly after as being
responsible of the autosomal form of EDMD (EDMD2,
OMIM#181350). The same gene, LMNA was then found
mutated in a large spectrum of disorders, now called
Laminopathies, affecting the skeletal and cardiac striated
muscles, the peripheral nerves, the adipose tissue or lead-
ing to segmental premature ageing syndromes. These dis-
coveries have shed light on the nuclear envelope, and
mutations in genes encoding other nuclear envelope pro-
teins were regularly reported in cascade during the last
15 years.
The French network on ‘EDMD & other nuclear envel-
ope related diseases’ directed by Drs. Gisèle Bonne, Rabah
Ben Yaou and France Leturcq (Paris), organizes annual
meetings since it has been created in 2000. The Italian Net-
work for Laminopathies, directed by Dr Giovanna Lattanzi
(Bologna) and established in 2009, convene meetings twice
a year. On January, 15-16, 2015, for the first time, the two
networks held a joint meeting in Marseille at La Timone
Adults’ Hospital: The 1st French-Italian meeting on lami-
nopathies & other nuclear envelope-related diseases. This
meeting was organized by Dr. Annachiara De Sandre-
Giovannoli and Pr. Nicolas Lévy and the directors of the
French and Italian networks. The meeting aimed to pro-
vide an update of recently acquired knowledge on: i) precli-
nical researches, ii) clinical researches, iii) patient registry
and databases and iv) clinical trials in some of these rare
diseases. The meeting also provided an understanding of
the current state of the art on laminopathies and other
nuclear envelope related diseases across France, Italy and
the Iberian Peninsula and an opportunity to exchange
ideas to improve patients’ healthcare organization in
the future in a larger European/international context. The
meeting has gathered 108 participants during two days.
The first day was dedicated to communications among
professionals involved in diagnosis, research and treatment
of laminopathies and related diseases, and open to indus-
trial partners, and the second day was dedicated to com-
munications and view exchanges among professionals and
patients’ families, aiming to inform them of the state of the
art concerning their disease in terms of research and treat-
ment. Among the invited speakers, Dr. Carlos Lopez-Otin,
a leading scientist in the field of Progeria research,
Dr. Raoul Hennekam, an expert clinician in the diagnosis
and follow up of progeroid laminopathies and lipodystro-
phies, Dr. David Araujo-Vilar, the coordinator of the
European consortium on lipodystrophies. These two days
have been rich of view exchanges and informative for pro-
fessionals and patients’ families, and have helped to further
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develop novel as well as already established fruitful
collaborations.
It is planned not only to organize a second joint meet-
ing between the French and Italian networks, but also to
more widely open these meetings to other European col-
leagues, since already for this first edition, the Iberian
community was largely represented. No doubt that this
first edition will be the first one of a long series, since
nuclear envelope proteins and their related diseases are
extremely diverse and in continuous evolution.
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